Literature DB >> 23672544

Taking financial relationships into account when assessing research.

David B Resnik1, Kevin C Elliott.   

Abstract

Many scientific journals, government agencies, and universities require disclosure of sources of funding and financial interests related to research, such as stock ownership, consulting arrangements with companies, and patents. Although disclosure has become one of the central approaches for responding to financial conflicts of interest (COIs) in research, critics contend that information about financial COIs does not serve as a reliable indicator of research credibility, and therefore, studies should be evaluated solely based on their scientific merits. We argue that, while it is indeed important to evaluate studies on their scientific merits, it is often difficult to detect significant influences of financial relationships that affect research credibility. Moreover, at least five factors can be examined to determine whether financial relationships are likely to enhance, undermine, or have no impact on the credibility of research. These include as follows: whether sponsors, institutions, or researchers have a significant financial stake in the outcome of a study; whether the financial interests of the sponsors, institutions, or researchers coincide with the goal of conducting research that is objective and reliable; whether the sponsor, institution, or researchers have a history of biasing research in order to promote their financial goals; how easy it is to manipulate the research in order to achieve financial goals; and whether oversight mechanisms are in place which are designed to minimize bias. Since these factors vary from case to case, evaluating the impact of financial relationships depends on the circumstances. In some situations, one may decide that the financial relationships significantly undermine the study's credibility; in others, one may decide that they have no impact on credibility or even enhance it.

Entities:  

Mesh:

Year:  2013        PMID: 23672544      PMCID: PMC3954632          DOI: 10.1080/08989621.2013.788383

Source DB:  PubMed          Journal:  Account Res        ISSN: 0898-9621            Impact factor:   2.622


  52 in total

1.  Evaluation of conflict of interest in economic analyses of new drugs used in oncology.

Authors:  M Friedberg; B Saffran; T J Stinson; W Nelson; C L Bennett
Journal:  JAMA       Date:  1999-10-20       Impact factor: 56.272

2.  Conflict of interest and the public trust.

Authors:  C D DeAngelis
Journal:  JAMA       Date:  2000-11-01       Impact factor: 56.272

3.  Policies on faculty conflicts of interest at US universities.

Authors:  M K Cho; R Shohara; A Schissel; D Rennie
Journal:  JAMA       Date:  2000-11-01       Impact factor: 56.272

Review 4.  Scope and impact of financial conflicts of interest in biomedical research: a systematic review.

Authors:  Justin E Bekelman; Yan Li; Cary P Gross
Journal:  JAMA       Date:  2003 Jan 22-29       Impact factor: 56.272

5.  Is this clinical trial fully registered?--A statement from the International Committee of Medical Journal Editors.

Authors:  Catherine D De Angelis; Jeffrey M Drazen; Frank A Frizelle; Charlotte Haug; John Hoey; Richard Horton; Sheldon Kotzin; Christine Laine; Ana Marusic; A John P M Overbeke; Torben V Schroeder; Harold C Sox; Martin B Van Der Weyden
Journal:  N Engl J Med       Date:  2005-05-23       Impact factor: 91.245

6.  Extra scrutiny for industry funded trials.

Authors:  Kenneth J Rothman; Stephen Evans
Journal:  BMJ       Date:  2005-12-10

7.  Failure to discount for conflict of interest when evaluating medical literature: a randomised trial of physicians.

Authors:  Gabriel K Silverman; George F Loewenstein; Britta L Anderson; Peter A Ubel; Stanley Zinberg; Jay Schulkin
Journal:  J Med Ethics       Date:  2010-05       Impact factor: 2.903

8.  A new policy on tobacco papers.

Authors: 
Journal:  PLoS Med       Date:  2010-02-23       Impact factor: 11.069

Review 9.  Multiple roles for nicotine in Parkinson's disease.

Authors:  Maryka Quik; Luping Z Huang; Neeraja Parameswaran; Tanuja Bordia; Carla Campos; Xiomara A Perez
Journal:  Biochem Pharmacol       Date:  2009-05-09       Impact factor: 5.858

10.  Industry testing of toxic pesticides on human subjects concluded "no effect," despite the evidence.

Authors:  Jennifer B Sass; Herbert L Needleman
Journal:  Environ Health Perspect       Date:  2004-03       Impact factor: 9.031

View more
  8 in total

1.  Declarations, accusations and judgement: examining conflict of interest discourses as performative speech-acts.

Authors:  Christopher Mayes; Wendy Lipworth; Ian Kerridge
Journal:  Med Health Care Philos       Date:  2016-09

2.  The Ethical Challenges of Socially Responsible Science.

Authors:  David B Resnik; Kevin C Elliott
Journal:  Account Res       Date:  2016       Impact factor: 2.622

3.  The Influence of Disclosure and Ethics Education on Perceptions of Financial Conflicts of Interest.

Authors:  Donald F Sacco; Samuel V Bruton; Alen Hajnal; Chris J N Lustgraaf
Journal:  Sci Eng Ethics       Date:  2014-07-10       Impact factor: 3.525

4.  Science and money: problems and solutions.

Authors:  David B Resnik
Journal:  J Microbiol Biol Educ       Date:  2014-12-15

5.  Effect of revealing authors' conflicts of interests in peer review: randomized controlled trial.

Authors:  Leslie K John; George Loewenstein; Andrew Marder; Michael L Callaham
Journal:  BMJ       Date:  2019-11-06

6.  Letter regarding "Puppyhood diet as a factor in the development of owner-reported allergy/atopy skin signs in adult dogs in Finland".

Authors:  Brennen McKenzie; Jennifer Larsen
Journal:  J Vet Intern Med       Date:  2022-07-22       Impact factor: 3.175

7.  Science, policy, and the transparency of values.

Authors:  Kevin C Elliott; David B Resnik
Journal:  Environ Health Perspect       Date:  2014-03-25       Impact factor: 9.031

8.  Systematic overview of hepatitis C infection in the Middle East and North Africa.

Authors:  Karima Chaabna; Sohaila Cheema; Amit Abraham; Hekmat Alrouh; Albert B Lowenfels; Patrick Maisonneuve; Ravinder Mamtani
Journal:  World J Gastroenterol       Date:  2018-07-21       Impact factor: 5.742

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.